AAAAAA

   
Results: 1-23 |
Results: 23
Usefulness of biochemical markers of bone turnover in assessing response to the treatment of Paget's disease
Authors: Alvarez, L Guanabens, N Peris, P Vidal, S Ros, I Monegal, A Bedini, JL Deulofeu, R Pons, F Munoz-Gomez, J Ballesta, AM
Citation: L. Alvarez et al., Usefulness of biochemical markers of bone turnover in assessing response to the treatment of Paget's disease, BONE, 29(5), 2001, pp. 447-452
Influence of AFP, CEA and PSA on the in vitro production of cytokines
Authors: Filella, X Molina, R Alcover, J Coca, F Zarco, MA Ballesta, AM
Citation: X. Filella et al., Influence of AFP, CEA and PSA on the in vitro production of cytokines, TUMOR BIOL, 22(2), 2001, pp. 67-71
Circulating levels of Th1/Th2 cytokines in patients with primary Sjogren'ssyndrome: Correlation with clinical and immunological features
Authors: Garcia-Carrasco, M Font, J Filella, X Cervera, R Ramos-Casals, M Siso, A Aymami, A Ballesta, AM Ingelmo, M
Citation: M. Garcia-carrasco et al., Circulating levels of Th1/Th2 cytokines in patients with primary Sjogren'ssyndrome: Correlation with clinical and immunological features, CLIN EXP RH, 19(4), 2001, pp. 411-415
Collagen type I alpha I and vitamin D receptor gene polymorphisms and bonemass in primary biliary cirrhosis
Authors: Pares, A Guanabens, N Alvarez, L De Osaba, MJM Oriola, J Pons, F Caballeria, L Monegal, A Salvador, G Jo, J Peris, P Rivera, F Ballesta, AM Rodes, J
Citation: A. Pares et al., Collagen type I alpha I and vitamin D receptor gene polymorphisms and bonemass in primary biliary cirrhosis, HEPATOLOGY, 33(3), 2001, pp. 554-560
Components of biological variation of biochemical markers of bone turnoverin Paget's bone disease
Authors: Alvarez, L Ricos, C Peris, P Guanabens, N Monegal, A Pons, F Ballesta, AM
Citation: L. Alvarez et al., Components of biological variation of biochemical markers of bone turnoverin Paget's bone disease, BONE, 26(6), 2000, pp. 571-576
Collagen type I alpha 1 gene polymorphism in idiopathic osteoporosis in men
Authors: Peris, P Alvarez, L Oriola, J Guanabens, N Monegal, A de Osaba, MJM Jo, J Pons, F Ballesta, AM Munoz-Gomez, J
Citation: P. Peris et al., Collagen type I alpha 1 gene polymorphism in idiopathic osteoporosis in men, RHEUMATOLOG, 39(11), 2000, pp. 1222-1225
Analysis of type T1 and T2 cytokines in patients with prostate cancer
Authors: Filella, X Alcover, J Zarco, MA Beardo, P Molina, R Ballesta, AM
Citation: X. Filella et al., Analysis of type T1 and T2 cytokines in patients with prostate cancer, PROSTATE, 44(4), 2000, pp. 271-274
Measurement of complexed PSA in the differential diagnosis between prostate cancer and benign prostate hyperplasia
Authors: Filella, X Alcover, J Molina, R Corral, JM Carretero, P Ballesta, AM
Citation: X. Filella et al., Measurement of complexed PSA in the differential diagnosis between prostate cancer and benign prostate hyperplasia, PROSTATE, 42(3), 2000, pp. 181-185
Usefulness of urinary nuclear matrix protein 22 (NMP22) as a marker for transtional cell carcinoma of the bladder
Authors: Menendez, V Filella, X Alcover, JA Molina, R Mallafre, JM Ballesta, AM Talbot-Wright, R
Citation: V. Menendez et al., Usefulness of urinary nuclear matrix protein 22 (NMP22) as a marker for transtional cell carcinoma of the bladder, ANTICANC R, 20(2B), 2000, pp. 1169-1172
S-adenosylmethionine prevents hepatic tocopherol depletion in carbon tetrachloride-injured rats
Authors: Deulofeu, R Pares, A Rubio, M Gasso, M Roman, J Gimenez, A Varela-Moreiras, G Caballeria, J Ballesta, AM Mato, JM Rodes, J
Citation: R. Deulofeu et al., S-adenosylmethionine prevents hepatic tocopherol depletion in carbon tetrachloride-injured rats, CLIN SCI, 99(4), 2000, pp. 315-320
Malignant hypertrophic cardiomyopathy caused by the Arg723Gly mutation in beta-myosin heavy chain gene
Authors: Enjuto, M Francino, A Navarro-Lopez, F Viles, D Pare, JC Ballesta, AM
Citation: M. Enjuto et al., Malignant hypertrophic cardiomyopathy caused by the Arg723Gly mutation in beta-myosin heavy chain gene, J MOL CEL C, 32(12), 2000, pp. 2307-2313
Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy
Authors: Peris, P Alvarez, L Monegal, A Guanabens, N Duran, M Pons, F De Osaba, MJM Echevarria, M Ballesta, AM Munoz-Gomez, J
Citation: P. Peris et al., Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy, BONE, 25(3), 1999, pp. 349-353
Evaluation of a multivariate prostate-specific antigen and percentage of free prostate-specific antigen logistic regression model in the diagnosis ofprostate cancer
Authors: Filella, X Alcover, J Quinto, L Molina, R Bosch-Capblanch, X Carretero, P Ballesta, AM
Citation: X. Filella et al., Evaluation of a multivariate prostate-specific antigen and percentage of free prostate-specific antigen logistic regression model in the diagnosis ofprostate cancer, TUMOR BIOL, 20(6), 1999, pp. 312-318
C-erbB-2 CEA and CA 15.3 serum levels in the early diagnosis of recurrencein breast cancer patients
Authors: Molina, R Jo, J Filella, X Zanon, G Farrus, B Munoz, M Latre, ML Pahisa, J Velasco, M Fernandez, P Estape, J Ballesta, AM
Citation: R. Molina et al., C-erbB-2 CEA and CA 15.3 serum levels in the early diagnosis of recurrencein breast cancer patients, ANTICANC R, 19(4A), 1999, pp. 2551-2555
Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse
Authors: Molina, R Farrus, B Filella, X Jo, J Zanon, G Pahisa, J Latre, M Munoz, M Ballesta, AM
Citation: R. Molina et al., Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse, ANTICANC R, 19(4A), 1999, pp. 2557-2562
First-trimester biochemical markers for Down syndrome
Authors: Casals, E Aibar, C Martinez, JM Borrell, A Soler, A Ojuel, J Ballesta, AM Fortuny, A
Citation: E. Casals et al., First-trimester biochemical markers for Down syndrome, PRENAT DIAG, 19(1), 1999, pp. 8-11
High bilirubin levels interfere with serum tartrate-resistant acid phosphatase determination: Relevance as a marker of bone resorption in jaundiced patients
Authors: Alvarez, L Peris, P Bedini, JL Pares, A Monegal, A Guanabens, N Mas, E Aibar, C Ballesta, AM
Citation: L. Alvarez et al., High bilirubin levels interfere with serum tartrate-resistant acid phosphatase determination: Relevance as a marker of bone resorption in jaundiced patients, CALCIF TIS, 64(4), 1999, pp. 301-303
Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity
Authors: Pons, F Alvarez, L Peris, P Guanabens, N Vidal-Sicart, S Monegal, A Pavia, J Ballesta, AM Munos-Gomez, J Herranz, R
Citation: F. Pons et al., Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity, NUCL MED C, 20(6), 1999, pp. 525-528
S-adenosyl L-methionine effect on hepatic allografts procured from non-heart-beating donor pigs
Authors: Net, M Garcia-Valdecasas, JC Deulofeu, R Gonzalez, X Palacin, J Almenara, R Valero, R Lopez-Boado, M Angas, J Elena, M Ballesta, AM Visa, J
Citation: M. Net et al., S-adenosyl L-methionine effect on hepatic allografts procured from non-heart-beating donor pigs, TRANSPLAN P, 31(1-2), 1999, pp. 1063-1064
Clinical usefulness of biochemical markers of bone turnover
Authors: Alvarez, L Guanabens, N Peris, P Ballesta, AM
Citation: L. Alvarez et al., Clinical usefulness of biochemical markers of bone turnover, MED CLIN, 112(13), 1999, pp. 517-518
Collagen type I alpha 1 gene Sp1 polymorphism in premenopausal women with primary osteoporosis: Improved detection of Sp1 binding site polymorphism in the collagen type 1 gene.
Authors: Alvarez, L Oriola, J Jo, J Ferro, T Pons, F Peris, P Guanabens, N Duran, M Monegal, A de Osaba, MJM Rivera-Fillat, F Ballesta, AM
Citation: L. Alvarez et al., Collagen type I alpha 1 gene Sp1 polymorphism in premenopausal women with primary osteoporosis: Improved detection of Sp1 binding site polymorphism in the collagen type 1 gene., CLIN CHEM, 45(6), 1999, pp. 904-906
Impaired production of interleukin 6 and tumour necrosis factor alpha in whole blood cell cultures of patients with multiple myeloma
Authors: Filella, X Blade, J Montoto, S Molina, R Coca, F Montserrat, E Ballesta, AM
Citation: X. Filella et al., Impaired production of interleukin 6 and tumour necrosis factor alpha in whole blood cell cultures of patients with multiple myeloma, CYTOKINE, 10(12), 1998, pp. 993-996
c-erbB-2 oncoprotein, CEA, and CA15.3 in patients with breast cancer: prognostic value
Authors: Molina, R Jo, J Filella, X Zanon, G Pahisa, J Munoz, M Farrus, B Latre, ML Escriche, C Estape, J Ballesta, AM
Citation: R. Molina et al., c-erbB-2 oncoprotein, CEA, and CA15.3 in patients with breast cancer: prognostic value, BREAST CANC, 51(2), 1998, pp. 109-119
Risultati: 1-23 |